Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kang Na

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
BMC Cardiovascular Disorders|February 5, 2022
Acute left ventricular insufficiency in a Burkitt Lymphoma patient with myocardial involvement and extensive local tumor cell lysis: a case reportMaren Schmiester, Eva Tranter, Alessandro Lorusso, et al.
Human Pathology|August 15, 2008
Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasisIl-Kang Na, Carmen Scheibenbogen, Christine Adam, et al.
Ejhaem|September 2, 2022
Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controlsNina Winkelmann, Michaela Schwarz, Bert Hildebrandt, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2006
Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cellsIl-Kang Na, Ulrich Keilholz, Anne Letsch, et al.
International Journal of Hematologic Oncology|January 7, 2020
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy responseSophy Denker, Aitomi Bittner, Il-Kang Na, et al.
International Journal of Molecular Sciences|March 25, 2022
Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival OutcomeElisa Ciraolo, Stefanie Althoff, Josefine Ruß, et al.
Clinical Immunology (Orlando, Fla.)|September 7, 2015
Altered B-cell subsets and functional B-cell defects in selective IgM deficiencyAngela Mensen, Torben Krause, Leif Gunnar Hanitsch, et al.
Blood|June 22, 2005
Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphomaKristoph Jahnke, Sarah E Coupland, Il-Kang Na, et al.
Cancer|January 9, 2008
Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunitsAntonia Busse, Marianne Kraus, Il-Kang Na, et al.
Blood|December 24, 2005
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2Robert Godal, Ulrich Keilholz, Lutz Uharek, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
BMC Cardiovascular Disorders|February 5, 2022
Acute left ventricular insufficiency in a Burkitt Lymphoma patient with myocardial involvement and extensive local tumor cell lysis: a case reportMaren Schmiester, Eva Tranter, Alessandro Lorusso, et al.
Human Pathology|August 15, 2008
Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasisIl-Kang Na, Carmen Scheibenbogen, Christine Adam, et al.
Ejhaem|September 2, 2022
Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controlsNina Winkelmann, Michaela Schwarz, Bert Hildebrandt, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2006
Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cellsIl-Kang Na, Ulrich Keilholz, Anne Letsch, et al.
International Journal of Hematologic Oncology|January 7, 2020
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy responseSophy Denker, Aitomi Bittner, Il-Kang Na, et al.
International Journal of Molecular Sciences|March 25, 2022
Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival OutcomeElisa Ciraolo, Stefanie Althoff, Josefine Ruß, et al.
Clinical Immunology (Orlando, Fla.)|September 7, 2015
Altered B-cell subsets and functional B-cell defects in selective IgM deficiencyAngela Mensen, Torben Krause, Leif Gunnar Hanitsch, et al.
Blood|June 22, 2005
Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphomaKristoph Jahnke, Sarah E Coupland, Il-Kang Na, et al.
Cancer|January 9, 2008
Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunitsAntonia Busse, Marianne Kraus, Il-Kang Na, et al.
Blood|December 24, 2005
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2Robert Godal, Ulrich Keilholz, Lutz Uharek, et al.
Pageof 9